Innovative Veterinary Focus Animol Discovery specializes in leveraging machine learning and DNA-encoded libraries to develop novel pharmaceuticals for veterinary patients, presenting opportunities to collaborate with veterinary clinics, animal health companies, and pet care providers interested in cutting-edge veterinary treatments.
Recent Funding Growth With a recent Series B funding of 34 million dollars, Animol is expanding its R&D capabilities, indicating a growing demand for advanced veterinary pharmaceuticals and opening avenues for partners interested in co-development or licensing innovative drug candidates.
Strategic Leadership The appointment of Marijn Dekkers PhD to the Board of Directors enhances Animol's strategic insight and industry reputation, which can be advantageous in establishing partnerships with pharmaceutical investors and stakeholders seeking innovative biotech ventures.
Emerging Market Presence As a relatively small biotech with revenue in the low millions, Animol presents a high-growth opportunity for service providers in biotech research, clinical testing, or laboratory support services aiming to enter the veterinary drug discovery sector.
Technology-Driven Approach Utilizing advanced tech stacks like Oracle Cloud, Python, and Tailwind CSS, Animol is positioned as a technology-forward company, offering potential collaboration prospects with IT service providers or software vendors looking to partner with innovative biotech startups.
$500M$1B
$250M$500M
$100M$250M
$10M$25M
$1B$10B
$1B$10B
$1B$10B
$100M$250MAnimol Discovery, Inc. uses 8 technology products and services including Cloudflare, Oracle Cloud, oEmbed, and more. Explore Animol Discovery, Inc.'s tech stack below.
| Animol Discovery, Inc. Email Formats | Percentage |
| First.Last@animol-discovery.com | 100% |
Biotechnology ResearchMassachusetts, United States11-50 Employees
Animol is a drug discovery company that leverages the powerful combination of machine learning and DNA-encoded chemical libraries to build a proprietary pipeline of highly innovative pharmaceuticals for veterinary patients.
Company Overview
Funding & FinancialsAnimol Discovery, Inc. has raised a total of $4M of funding over 6 rounds. Their latest funding round was raised on Dec 11, 2024 in the amount of $4M.
Animol Discovery, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & FinancialsAnimol Discovery, Inc. has raised a total of $4M of funding over 6 rounds. Their latest funding round was raised on Dec 11, 2024 in the amount of $4M.
Animol Discovery, Inc.'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com